SAVIENT PHARMACEUTICALS INC·4/A

Jan 14, 1:56 PM ET

WEISSBACH HERBERT 4/A

4/A · SAVIENT PHARMACEUTICALS INC · Filed Jan 14, 2004

Insider Transaction Report

Form 4/AAmended
Period: 2003-09-30
Transactions
  • Award

    Common stock, $.01 par value per share

    2003-09-30$5.05/sh+495$2,5009,658 total
  • Award

    Options to purchase common stock, $.01 par value per share

    2003-09-30$5.05/sh+5,000$25,25080,000 total
    Exercise: $5.05From: 2004-09-30Exp: 2013-09-30Common stock, $01 par value per share (5,000 underlying)
Footnotes (3)
  • [F1]These shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On September 30, 2003, the fair market value of the Common Stock, based on the closing price, was $5.05.
  • [F2]These options will become fully vested and immediately exercisable on 9/30/2004.
  • [F3]This stock grant was originally reported in Table 1 Columns 3 and 4 with the incorrect transaction codes. The stock grant was originally reported in Column 3 as "D" instead of "A" and in Column 4 as "D" for securities disposed of instead of "A" for securities acquired.

Documents

1 file
  • 4
    edgar.xml

    PRIMARY DOCUMENT